Home Cart Sign in  
Chemical Structure| 1045809-78-6 Chemical Structure| 1045809-78-6

Structure of 1045809-78-6

Chemical Structure| 1045809-78-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1045809-78-6 ]

CAS No. :1045809-78-6
Formula : C9H14BNO2S
M.W : 211.09
SMILES Code : CC1(C)C(C)(C)OB(C2=CC=NS2)O1
MDL No. :MFCD08061126
InChI Key :UPECZVDBUMIIIL-UHFFFAOYSA-N
Pubchem ID :16761714

Safety of [ 1045809-78-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Application In Synthesis of [ 1045809-78-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1045809-78-6 ]

[ 1045809-78-6 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1045809-78-6 ]
  • [ 1212010-85-9 ]
  • [ 1311263-07-6 ]
  • 2
  • [ 1045809-78-6 ]
  • 2-[(3R)-3-methylmorpholin-4-yl]-8-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]-1,7-naphthyridin-4-yl trifluoromethanesulfonate [ No CAS ]
  • 2-[(3R)-3-methylmorpholin-4-yl]-8-[1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]-4-(1,2-thiazol-5-yl)-1,7-naphthyridine [ No CAS ]
YieldReaction ConditionsOperation in experiment
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; caesium carbonate; In 1,4-dioxane; at 110℃; for 2.0h;Inert atmosphere; A suspension of 100 mg (0.19 mmol) of 2-[(3R)-3-methylmorpholin-4-yl]-8-[1-(tetrahydro-2H- pyran-2-yl)-1H-pyrazol-5-yl]-1,7-naphthyridin-4-yl trifluoromethanesulfonate, 80 mg (0.38 mmol) <strong>[1045809-78-6]5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-thiazole</strong>, 15 mg (0.019 mmol) of [1,1?-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (1:1, Pd(dppf)C12) and 247 mg (0.76 mmol) of ceasium carbonate in 1.3 ml of dioxane was degased with argon. Under argon, the reaction mixture was stirred at 110C for 2 hours. After cooling the reaction mixture was diluted with saturated aqueous sodium chloride solution and extracted with ethyl acetate (2x). The combinded organic phases were filtered using a Whatman filter and thenconcentrated to give the crude product that was used without further purification in the next step.
  • 3
  • [ 1045809-78-6 ]
  • tert-butyl 4-{3-bromo-5-[(4-methoxybenzyl)oxy]pyrazolo[1,5-a]pyrimidin-7-yl}piperidine-1-carboxylate [ No CAS ]
  • tert-butyl 4-{5-[(4-methoxybenzyl)oxy]-3-(1,2-thiazol-5-yl)pyrazolo[1,5-a]pyrimidin-7-yl}piperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
26% With potassium phosphate; methanesulfonic acid(2-dicyclohexylphosphino-2?,4?,6?-triisopropyl-1,1?-biphenyl)[2-(2?-amino-1,1?-biphenyl)]palladium(II); In 1,4-dioxane; water; at 80 - 110℃;Inert atmosphere; To a suspension of tert-butyl 4-{3-bromo-5-[(4-methoxybenzyl)oxy]pyrazolo[l,5-a]pyrimidin-7- yl}piperidine-l-carboxylate (100 mg, 193 muiotaetaomicron) in 1,4-dioxan (4.0 ml) were added 5-(4,4,5,5- tetramethyl-l,3,2-dioxaborolan-2-yl)-l,2-thiazole (81.6 mg, 387 muiotaetaomicron), tripotassium phosphate (970 mu, 1.0 M in water, 970 muiotaetaomicron) and XPhos Pd G3 (4.09 mg, 4.83 muiotaetaomicron). The mixture was degased with argon for 2 min and stirred overnight at 110 C. A new portion of 5-(4,4,5,5-tetramethyl-l,3,2- dioxaborolan-2-yl)-l,2-thiazole (81.6 mg, 387 muiotaetaomicron) and XPhos Pd G3 (4.09 mg, 4.83 muiotaetaomicron) was added and the mixture was stirred for 2 h at 110 C. A last portion of 5-(4,4,5,5-tetramethyl-l,3,2- dioxaborolan-2-yl)-l,2-thiazole (81.6 mg, 387 muiotaetaomicron) and XPhos Pd G3 (4.09 mg, 4.83 muiotaetaomicron) was added and the mixture was stirred overnight at 80 C and 1 h more at 110 C. After cooling to room temperature, the mixture was purified by preparative HPLC (gradient acetonitrile/water with 0.1 % formic acid). Evaporation of the combined product fractions yielded the title compound. The obtained amount was 26.0 mg (100 % purity, 26 % of theory). LC-MS (Method 8B): Rt = 1.67 min; MS (ESIpos): m z = 522 [M+H]+
 

Historical Records

Categories